Dance Biopharm Inc. Email Format
Biotechnology ResearchNorth Carolina, United States11-50 Employees
Dance Biopharm Inc. is a small biotechnology research company based in Durham, North Carolina. It develops inhaled therapies for serious and rare cardiopulmonary and cardiometabolic conditions. Its lead program, AER-901, delivers imatinib by inhalation to treat pulmonary hypertension, aiming to address limitations associated with other delivery methods. It operates in the biopharmaceutical sector with a focus on inhaled therapeutics and a patient-centered approach that seeks to improve ease of use and quality of life. In 2023, the company disclosed Phase 1 trial data for AER-901 at the European Respiratory Society International Congress.